<DOC>
	<DOCNO>NCT02921698</DOCNO>
	<brief_summary>A prospective , multicenter , observational evaluation safety efficacy FRED® device treatment intracranial aneurysm .</brief_summary>
	<brief_title>Safety Efficacy Analysis FRED® Embolic Device Aneurysm Treatment</brief_title>
	<detailed_description />
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Intracranial Aneurysm</mesh_term>
	<criteria>1 . Patient age ≥18 year 2 . Patient unruptured recanalized intracranial aneurysm : endovascular treatment determine appropriate treated standard technique ( coil without remodel ) FRED® Flow Diverter determine appropriate treatment 3 . Patient patient 's legally authorize representative inform confidentiality study agree collection his/her personal data 4 . Patient present mRS score 0 2 5 . Patients already treat stent flow diverter another aneurysm may include : previous treatment three month prior enrollment study aneurysm treat study new aneurysm locate different parent vessel unless stent already place implant proximal carotid artery . 1 . Patient know allergy antiplatelet therapy , heparin and/or contrast medium 2 . Patient contraindication antiplatelet therapy and/or heparin 3 . Patient pregnant and/or breastfeed 4 . Patient may benefit image clinical monitoring 5 . Patient medical surgical comorbidities limit his/her life expectancy le 1 year 6 . Patient treat flow diverter FRED® 7 . Patient intracranial hemorrhage within 30 day precede treatment 8 . Patient aneurysm ( ) one follow characteristic : associate arteriovenous malformation dissect `` '' blisterlike '' '' multiple ( unless one aneurysm require treatment ) locate posterior circulation treat stent flow diverter parent vessel ( exclude proximal carotid artery ) 3 month prior inclusion 9 . Patient stenosis aneurysm parent artery .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>